Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Phase III
.
Show all posts
Showing posts with label
Phase III
.
Show all posts
Tuesday, June 16, 2026
Lilly's announces results from Phase III clinical trial of Jaypirca
›
In continuation of my update on pirtobrutinib Eli Lilly and Company announced results from the Phase 3 BRUIN CLL-322 clinical trial of Jayp...
Monday, June 8, 2026
Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
›
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the first Phase III (FENhance 2) of two pivotal, s...
Wednesday, June 8, 2016
Plitidepsin in combination with dexamethasone shows top-line results in Phase III multiple myeloma trial
›
In continuation of my updates on dexamethasone and Aplidin (plitidepsin) PharmaMar (MSE:PHM) announced positive top-line...
›
Home
View web version
